Alpha-beta adrenergic antagonist

This page covers all Alpha-beta adrenergic antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-1 adrenergic receptor, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor.

Targets

Alpha-1 adrenergic receptor, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor

Marketed (2)

• Experimental dosing of labetalol · Albany Medical College · Cardiovascular
  Labetalol is a combined alpha and beta-adrenergic receptor antagonist that reduces blood pressure by blocking both alpha-1 and beta-adrenergic signaling.
• labetalol intravenous · Haseki Training and Research Hospital · Cardiovascular
  Labetalol is a combined alpha and beta-adrenergic receptor antagonist that reduces blood pressure by blocking sympathetic nervous system signaling.